genepharm doxorubicin hydrochloride injection 10mg/5ml solution for injection vial
novotech australia pty ltd - doxorubicin hydrochloride -
doxorubicin ebewe 2mg/ml concentrate for solution for infusion
doxorubicin hydrochloride. - concentrate for solution for infusion - 1 ml contains 2 mg doxorubicin hydrochloride - doxorubicin
lipodox doxorubicin hydrochloride injectable liposomal
sun pharma global fze - doxorubicin hydrochloride (unii: 82f2g7bl4e) (doxorubicin - unii:80168379ag) - doxorubicin hydrochloride 2 mg in 1 ml
doxorubicin hydrochloride injectable, liposomal
zydus lifesciences limited - doxorubicin hydrochloride (unii: 82f2g7bl4e) (doxorubicin - unii:80168379ag) -
doxorubicin hydrochloride injection 200 mg in 100 ml (7)
pfizer (perth) pty ltd - doxorubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - doxorubicin hcl is indicated as a component of multi-agent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer. acute lymphoblastic leukemia acute myeloblastic leukemia hodgkin lymphoma non-hodgkin lymphoma metastatic breast cancer metastatic wilms? tumor metastatic neuroblastomas metastatic soft tissue sarcoma metastatic bone sarcoma metastatic ovarian carcinoma metastatic transitional cell bladder carcinoma metastatic thyroid carcinoma metastatic gastric carcinoma metastatic bronchogenic carcinoma
doxorubicin hydrochloride injection 50 mg in 25 ml (17)
pfizer (perth) pty ltd - doxorubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - doxorubicin hcl is indicated as a component of multi-agent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer. acute lymphoblastic leukemia acute myeloblastic leukemia hodgkin lymphoma non-hodgkin lymphoma metastatic breast cancer metastatic wilms? tumor metastatic neuroblastomas metastatic soft tissue sarcoma metastatic bone sarcoma metastatic ovarian carcinoma metastatic transitional cell bladder carcinoma metastatic thyroid carcinoma metastatic gastric carcinoma metastatic bronchogenic carcinoma
doxorubicin hydrochloride injection 20 mg in 10 ml (4)
pfizer (perth) pty ltd - doxorubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - doxorubicin hcl is indicated as a component of multi-agent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer. acute lymphoblastic leukemia acute myeloblastic leukemia hodgkin lymphoma non-hodgkin lymphoma metastatic breast cancer metastatic wilms? tumor metastatic neuroblastomas metastatic soft tissue sarcoma metastatic bone sarcoma metastatic ovarian carcinoma metastatic transitional cell bladder carcinoma metastatic thyroid carcinoma metastatic gastric carcinoma metastatic bronchogenic carcinoma
doxorubicin hydrochloride injection 10 mg in 5 ml (15)
pfizer (perth) pty ltd - doxorubicin hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - doxorubicin hcl is indicated as a component of multi-agent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer. acute lymphoblastic leukemia acute myeloblastic leukemia hodgkin lymphoma non-hodgkin lymphoma metastatic breast cancer metastatic wilms? tumor metastatic neuroblastomas metastatic soft tissue sarcoma metastatic bone sarcoma metastatic ovarian carcinoma metastatic transitional cell bladder carcinoma metastatic thyroid carcinoma metastatic gastric carcinoma metastatic bronchogenic carcinoma
doxorubicin sz
accord healthcare pty ltd - doxorubicin hydrochloride -
doxorubicin teva 2 mg/ml concentrate for solution for infusion
teva pharma b.v. - doxorubicin hydrochloride - concentrate for solution for infusion - 2 milligram(s)/millilitre - anthracyclines and related substances; doxorubicin